Medicare Part D coverage · 2 · RxCUI 2699122
2 ML bimekizumab-bkzx 160 MG/ML Auto-Injector [Bimzelx]
Per the CMS 2026 Part D formulary file, 2 ML bimekizumab-bkzx 160 MG/ML Auto-Injector [Bimzelx] is covered by 1,403 Medicare Part D plans (27.8% of enrollable products), averaging Tier 4.2, with prior authorization required on 98.5% of covering formularies.
- 27.8%
- Plan coverage
- 1,403
- Plans covering
- T4.2
- Avg tier
- 98.5%
- Prior auth required
What the CMS Formulary Data Shows for 2 ML bimekizumab-bkzx 160 MG/ML Auto-Injector [Bimzelx]
Per the CMS 2026 Part D formulary file, 2 ML bimekizumab-bkzx 160 MG/ML Auto-Injector [Bimzelx] (RxNorm concept RXCUI 2699122, generic name 2) appears on 66 distinct formulary files spanning 1,403 Medicare Part D plan offerings - 27.8% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.2.
Real-world access to 2 ML bimekizumab-bkzx 160 MG/ML Auto-Injector [Bimzelx] depends on utilization management as much as tier placement: 98.5% of covering formularies require prior authorization. 0% require step therapy. 90.9% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 13 Part D beneficiaries filled 2 ML bimekizumab-bkzx 160 MG/ML Auto-Injector [Bimzelx] in 2023, with total plan-and-beneficiary spending of $299,437 and an average per-beneficiary annual cost of $23,033.58. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 2 ML bimekizumab-bkzx 160 MG/ML Auto-Injector [Bimzelx] today.
Coverage Details
- Formularies covering
- 66
- Plans covering
- 1,403
- Coverage rate
- 27.8%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 98.5% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 90.9% of formularies
2023 Medicare Spending
- Beneficiaries
- 13
- Total spending
- $299,437
- Avg per beneficiary
- $23,033.58
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering 2 ML bimekizumab-bkzx 160 MG/ML Auto-Injector [Bimzelx]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Florida Complete Care-Duals VIP (HMO-POS D-SNP) | Hpmp OF Florida, Inc. | T1 | Yes | $0 | FL |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | Yes | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | Yes | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | Yes | $0 | AZ |
| Elderplan Plus Long-Term Care (HMO-POS D-SNP) | Elderplan, Inc. | T1 | Yes | $0 | NY |
| Health Choice Pathway (HMO D-SNP) | Health Choice Arizona, Inc. | T1 | Yes | $0 | AZ |
| Healthfirst CompleteCare (HMO D-SNP) | Healthfirst Health Plan, Inc. | T1 | Yes | $0 | NY |
| IMCare Classic (HMO D-SNP) | Itasca Medical Care | T1 | Yes | $0 | MN |
| Johns Hopkins Advantage MD D-SNP (HMO D-SNP) | Hopkins Health Advantage, Inc. | T1 | Yes | $0 | MD |
| MetroPlus UltraCare (HMO D-SNP) | Metroplus Health Plan, Inc. | T1 | Yes | $0 | NY |
| Senior Whole Health SCO (HMO D-SNP) | Senior Whole Health, LLC | T1 | Yes | $0 | MA |
| Senior Whole Health SCO NHC (HMO D-SNP) | Senior Whole Health, LLC | T1 | Yes | $0 | MA |
| Molina One Care (HMO D-SNP) | Senior Whole Health, LLC | T1 | Yes | $0 | MA |
| NaviCare (HMO D-SNP) | Fallon Community Health Plan | T1 | Yes | $0 | MA |
| CCA One Care (HMO D-SNP) | Commonwealth Care Alliance, Inc. | T1 | Yes | $0 | MA |
| CCA Senior Care Options (HMO D-SNP) | Commonwealth Care Alliance, Inc. | T1 | Yes | $0 | MA |
| Florida Complete Care (HMO I-SNP) | Hpmp OF Florida, Inc. | T1 | Yes | $4.80 | FL |
| Florida Complete Care- In The Community (HMO-POS I-SNP) | Hpmp OF Florida, Inc. | T1 | Yes | $4.80 | FL |
| Elderplan For Medicaid Beneficiaries (HMO-POS D-SNP) | Elderplan, Inc. | T1 | Yes | $22.70 | NY |
| VIVA Medicare Extra Value (HMO D-SNP) | Viva Health, Inc. | T1 | Yes | $27.70 | AL |
Show the next 30 plans
| VIVA Medicare Extra Care (HMO D-SNP) | Viva Health, Inc. | T1 | Yes | $27.70 | AL |
| Elderplan Advantage For Nursing Home Residents (HMO-POS I-SNP) | Elderplan, Inc. | T1 | Yes | $44.80 | NY |
| MetroPlus Platinum Plan (HMO) | Metroplus Health Plan, Inc. | T1 | Yes | $58.80 | NY |
| CalOptima Health OneCare Complete (HMO D-SNP) | Orange County Health Authority | T2 | Yes | $0 | CA |
| Aetna Medicare Signature (HMO) | Aetna Health OF California Inc. | T5 | Yes | $0 | CA |
| Aetna Medicare Signature (HMO) | Aetna Health OF California Inc. | T5 | Yes | $0 | CA |
| Aetna Medicare Signature Extra (HMO-POS) | Aetna Health OF California Inc. | T5 | Yes | $0 | CA |
| Aetna Medicare Prime (HMO-POS) | Aetna Health OF California Inc. | T5 | Yes | $0 | CA |
| Aetna Medicare Prime (HMO-POS) | Aetna Health OF California Inc. | T5 | Yes | $0 | CA |
| Aetna Medicare Prime (HMO-POS) | Aetna Health OF California Inc. | T5 | Yes | $0 | CA |
| Aetna Medicare Signature Extra (HMO) | Aetna Health OF California Inc. | T5 | Yes | $0 | CA |
| Aetna Medicare Prime (HMO-POS) | Aetna Health OF California Inc. | T5 | Yes | $0 | CA |
| Aetna Medicare Signature Extra (HMO) | Aetna Health OF California Inc. | T5 | Yes | $0 | CA |
| Aetna Medicare Signature Extra (HMO) | Aetna Health OF California Inc. | T5 | Yes | $0 | CA |
| Aetna Medicare Signature Extra (HMO) | Aetna Health OF California Inc. | T5 | Yes | $0 | CA |
| Aetna Medicare Signature Care (HMO-POS) | Aetna Health OF Ohio Inc. | T5 | Yes | $0 | OH |
| Aetna Medicare Signature Extra (HMO-POS) | Aetna Health OF Ohio Inc. | T5 | Yes | $0 | OH |
| Aetna Medicare Signature Care (HMO-POS) | Aetna Health OF Ohio Inc. | T5 | Yes | $0 | OH |
| Aetna Medicare Signature Extra (HMO-POS) | Aetna Health OF Ohio Inc. | T5 | Yes | $0 | KY |
| Aetna Medicare Signature (HMO-POS) | Aetna Health OF Ohio Inc. | T5 | Yes | $0 | KY |
| Aetna Medicare Signature (HMO-POS) | Aetna Health OF Ohio Inc. | T5 | Yes | $0 | KY |
| Aetna Medicare HIDE (HMO D-SNP) | Aetna Health OF Ohio Inc. | T5 | Yes | $0 | KY |
| Aetna Medicare Dual Care (HMO D-SNP) | Aetna Health OF Ohio Inc. | T5 | Yes | $0 | OH |
| Aetna Medicare Signature Care (HMO-POS) | Aetna Health OF Ohio Inc. | T5 | Yes | $0 | OH |
| Aetna Medicare Signature (HMO-POS) | Aetna Health OF Ohio Inc. | T5 | Yes | $0 | OH |
| Aetna Medicare Signature (HMO-POS) | Aetna Health OF Ohio Inc. | T5 | Yes | $0 | KY |
| Aetna Medicare Partial Dual (HMO D-SNP) | Aetna Health OF Ohio Inc. | T5 | Yes | $0 | KY |
| Aetna Medicare Partial Dual (HMO D-SNP) | Aetna Health OF Ohio Inc. | T5 | Yes | $0 | OH |
| Aetna Medicare Signature (HMO) | Aetna Health Inc. (GA) | T5 | Yes | $0 | GA |
| Aetna Medicare Signature (HMO-POS) | Coventry Health Care OF Illinois, Inc. | T5 | Yes | $0 | WI |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is 2 ML bimekizumab-bkzx 160 MG/ML Auto-Injector [Bimzelx] covered by Medicare Part D?
Yes, 2 ML bimekizumab-bkzx 160 MG/ML Auto-Injector [Bimzelx] is covered by 1,403 Medicare Part D plans (27.8% of all Part D formularies).
What tier is 2 ML bimekizumab-bkzx 160 MG/ML Auto-Injector [Bimzelx] on Medicare Part D plans?
2 ML bimekizumab-bkzx 160 MG/ML Auto-Injector [Bimzelx] averages Tier 4.2 across Part D plans, ranging from Tier 1 to Tier 5.
Does 2 ML bimekizumab-bkzx 160 MG/ML Auto-Injector [Bimzelx] require prior authorization?
98.5% of Part D formularies require prior authorization for 2 ML bimekizumab-bkzx 160 MG/ML Auto-Injector [Bimzelx]. Step therapy: 0%. Quantity limits: 90.9%.
How much does Medicare spend on 2 ML bimekizumab-bkzx 160 MG/ML Auto-Injector [Bimzelx]?
In 2023, total Medicare Part D spending on 2 ML bimekizumab-bkzx 160 MG/ML Auto-Injector [Bimzelx] was $299,437, covering 13 beneficiaries. The average spend per beneficiary was $23,033.58.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- amikacin liposomal 70.3 MG/ML Inhalation Suspension [Arikayce] T4.2
- cannabidiol 100 MG/ML Oral Solution [Epidiolex] T4.2
- fecal microbiota spores, live-brpk 30000000 UNT Oral Capsule [Vowst] T4.2
- fenfluramine 2.2 MG/ML Oral Solution [Fintepla] T4.2
- ganaxolone 50 MG/ML Oral Suspension [Ztalmy] T4.2
- ibrutinib 140 MG Oral Capsule [Imbruvica] T4.2
Similar prior-authorization rate
- 1 ML galcanezumab-gnlm 100 MG/ML Prefilled Syringe [Emgality] 98.5% PA
- tobramycin 75 MG/ML Inhalation Solution 98.5% PA
- 0.68 ML vedolizumab 159 MG/ML Auto-Injector [Entyvio] 98.5% PA
- amphotericin B liposomal 50 MG Injection 98.5% PA
- {28 (tolvaptan 30 MG Oral Tablet) / 28 (tolvaptan 60 MG Oral Tablet) } Pack 98.5% PA
- {56 (tolvaptan 15 MG Oral Tablet) } Pack 98.5% PA